RankingsPricing
  1. JP-listed companies
  2. Nxera Pharma Co., Ltd.
  3. Financials
  4. Cash from financing

Nxera Pharma Co., Ltd.【JP:4565】

Market cap
¥78.2B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from financing (Million JPY)YoY (%)
Dec 31, 2024-6,854-114.18%
Dec 31, 202348,329-1088.93%
Dec 31, 2022-4,887-143.94%
Dec 31, 202111,123-45.15%
Dec 31, 202020,278-391.18%
Dec 31, 2019-6,964+207.05%
Dec 31, 2018-2,268-110.02%
Mar 31, 201822,641-458.81%
Mar 31, 2017-6,310-831.17%
Mar 31, 2016863-95.66%
Mar 31, 201519,864+354.03%
Mar 31, 20144,375+4761.11%
Mar 31, 201390

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)